Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

University of Alabama at Birmingham, Birmingham, Alabama, United States

Banner MD Anderson Cancer Center, Gilbert, Arizona, United States

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

UCLA Hematology/Oncology - Westwood (Building 200 Suite 214), Los Angeles, California, United States

UCSF Helen Diller Medical Center at Parnassus Heights, San Francisco, California, United States

Colorado Blood Cancer Institute, Denver, Colorado, United States

Mayo Clinic in Florida, Jacksonville, Florida, United States

Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States

Moffitt Cancer Center, Tampa, Florida, United States

Winship Cancer Institute of Emory University, Atlanta, Georgia, United States

Northside Hospital, Atlanta, Georgia, United States

Northwestern Memorial Hospital, Chicago, Illinois, United States

University of Chicago Medical Center, Chicago, Illinois, United States

University of Iowa, Iowa City, Iowa, United States

The University of Kansas Cancer Center - Westwood, Westwood, Kansas, United States

Norton Women's and Children's Hospital, Louisville, Kentucky, United States

Local Institution - 0065, Baltimore, Maryland, United States

Massachusetts General Hospital, Boston, Massachusetts, United States

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Mayo Clinic in Rochester, Minnesota, Rochester, Minnesota, United States

Washington University School of Medicine, St Louis, Missouri, United States

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Roswell Park Cancer Institute, Buffalo, New York, United States

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Memorial Sloan Kettering Cancer Center, New York, New York, United States

University of North Carolina Medical Center, Chapel Hill, North Carolina, United States

Local Institution - 0067, Charlotte, North Carolina, United States

Oncology Hematology Care, Cincinnati, Ohio, United States

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Oregon Health and Science University, Portland, Oregon, United States

Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia, Pennsylvania, United States

Tennessee Oncology, Nashville, Tennessee, United States

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Local Institution - 0069, Austin, Texas, United States

UT Southwestern Medical Center, Dallas, Texas, United States

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Methodist HealthCare System of San Antonio Clinical Trials Office, Texas Transplant Institute, San Antonio, Texas, United States

LDS Hospital, Salt Lake City, Utah, United States

Virginia Oncology Associates, Norfolk, Virginia, United States

Fred Hutchinson Cancer Center, Seattle, Washington, United States

University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States

Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia

The Alfred Hospital, Melbourne, Victoria, Australia

St Vincent's Hospital, Melbourne, Victoria, Australia

Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta, Canada

McGill University Health Centre, Montreal, Quebec, Canada

Nagoya City University Hospital, Nagoya, Aichi-ken, Japan

Hyogo Medical University Hospital, Nishinomiya, Hyōgo, Japan

Chiba University Hospital, Chiba, Japan

University Hospital,Kyoto Prefectural University of Medicine, Kyoto, Japan

Japanese Red Cross Medical Center, Tokyo, Japan